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Abstract
Background: In a previously published study, we found that large differentiated subpopulations of CD8 T-cells emerged
rapidly after CMV infection in young infants and persisted throughout the following year. Here we describe a follow-up
study conducted on the same infants to establish whether the differentiated subpopulations continued through the second
year post-infection.
Methodology / Principal Findings: CMV-specific cells identified using tetramers remained more activated and differentiated
than the overall CD8 population. The large subpopulation of differentiated cytotoxic (CD28
2CD62L
2Bcl-2
lowCD95
+per-
forin
+) cells that emerged rapidly after infection remained stable after two years. No similar subpopulation was found in
CMV-uninfected infants indicating that two years after infection, CMV remained a major factor in driving CD8 T-cell
differentiation. Although markers of activation (CD45R0 and HLA-D) declined throughout the first year, HLA-D expression
continued to decline during the second year and CD45R0 expression increased slightly. The age-related increase in IFNc
response observed during the first year continued but was non-significant during the second year, indicating that the rate
of functional improvement had slowed substantially.
Conclusions / Significance: The large differentiated subpopulations of CD8 T-cells that had emerged immediately after CMV
infection persisted through the second year post-infection, while levels of activation and functional capacity remained fairly
constant.
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Introduction
Human cytomegalovirus (CMV) is a persistent herpesvirus that
establishes a lifelong but usually subclinical infection [1]. In adults,
infection induces large clones of CMV-specific T-cells that are
maintained after viraemia subsides and the infection enters the
chronic stage [2]. Over 5% of T-cells typically produce IFNc in
response to CMV [3], and individual clones identified by tetramer
staining are often much larger [4,5].
The CD8 T-cell responses of chronically infected adults are
characterised by large subpopulations of differentiated cells [6–8].
The subpopulations are maintained throughout adulthood,
although they expand in the elderly [6,9] which implies that the
differentiated populations remain stable or increase over time.
The relationship between the CD8 T-cells and CMV is
evidently complex, as while a strong CD8 T-cell response is
unable to prevent viral excretion in healthy individuals [4] or
CMV-associated pathology in renal transplant recipients [2],
immunity to chronic CMV infection following bone marrow
transplant has been re-established by reconstitution of the CD8 T-
cell clones specific for CMV [10]. In healthy people, CMV has
been linked to influenza vaccine failure in the elderly [11,12],
implying that CD8-mediated control of CMV infection carries a
physiological cost at least in the late stages of life.
Most studies have been carried out in high income countries
where CMV infection usually occurs in adulthood [1]. Neverthe-
less, the emergence of large CMV-specific clones similar to those
found in adults has been found in young children in the USA [4].
In low income countries, CMV infection is ubiquitous and
usually occurs in infancy [1,13], which offers the opportunity to
recruit a prospective cohort to study the interaction of the infant
immune system with a viral infection. We recruited a cohort of
PLoS ONE | www.plosone.org 1 August 2008 | Volume 3 | Issue 8 | e2905Gambian infants at birth and monitored them for the onset of
CMV infection during the first year of life and evaluated the
development of the CD8 T-cell response over two years following
infection.
We found that the median age of diagnosis of CMV infection
was eight weeks [14], which was considerably lower than in any
other cohort studied. The large clones of CMV-specific cells and
large subpopulations of differentiated (CD28
2, CD62L
2, Bcl-2
low,
CD95
+, perforin
+, granzyme A
+) cells appeared in the same way as
in adults or older children, while very few differentiated CD8 T-
cells were present in CMV-uninfected infants of the same age. The
phenotype of CMV-specific cells was both more differentiated and
more activated (CD45R0
+, HLA-D
+) than the phenotype of the
overall CD8 T-cell population, though levels of activation fell
throughout the first year to the extent that by 12 months post-
diagnosis, activation in the overall CD8 T-cell population was
similar in CMV-infected and uninfected infants of the same age.
However, IFNc production in response to class I restricted CMV
peptides was relatively low in the younger infants sampled,
indicating that the functional potential of the infants’ CD8 T-cells
was not as well developed as their phenotypic maturity suggested
and was independent of the declining levels of activation [15].
We subsequently sampled a subset of subjects at the end of the
second year post-diagnosis, and here we compare the phenotype
and function of CD8 T-cells after 12 and 24 months of CMV
infection.
Methods
Subjects
The initial protocol for the study of the development of the CD8
T-cell response to CMV involved sampling infected infants up to
one year after infection and uninfected infants when they reached
twelve months of age [15]. It was not logistically possible to follow
up the whole cohort for a second year so a subcohort that included
infants infected at various ages was identified for sampling at 24
months post-diagnosis, or at 24 months of age among infants that
had remained uninfected by 12 months of age. Recruitment of the
subcohort was biased towards those infants whose CD8 T-cells
bound the available tetramers, and was intended to ensure that
infants infected early and late in the first year of life were
represented. It consisted of two infants that were infected
congenitally, eight infected at 5–9 weeks of age, ten infected at
20–40 weeks of age and two that had not been infected by 24
months of age. The 12 month post-diagnosis sample was collected
from infants with ages ranging from 47 to 71 weeks with a mean of
65, while the 24 month post-diagnosis sample was collected from
infants with ages ranging from 103 to 144 weeks with a mean of
117.
Infants were recruited at birth from the maternity ward of
Sukuta Health Centre. Informed consent was obtained from their
mothers and documented by signature or thumb print at birth,
and consent was confirmed at the end of the first year following
diagnosis. Recruitment was restricted to healthy singleton infants,
defined by a birth weight of at least 1.95 kg, without congenital
abnormalities. The catchment area of Sukuta Health Centre is
peri-urban, and characterised by low income and crowded living
conditions. The HIV status of study subjects was unknown, but
adult prevalence in the region was 1–4% at the time of the study
(National AIDS Control Program, unpublished data) so is unlikely
to be a significant confounder of this study.
Limited molecular HLA typing was carried out as previously
described [16,17] on buffy coats obtained from umbilical cord
blood separated on a lymphoprep column (Axis-Shield plc,
Dundee, Scotland) in order to identify subjects with HLA- A2,
B7, B8 and B35 for which known epitope peptides were available.
The study was approved by the Medical Research Council
(MRC)-Gambian Government Ethics Committee.
Sample collection and diagnosis of CMV
A 5 ml venous blood sample was collected into heparin and
transported to the laboratory within 4 h. Whole blood was used
for flow cytometry, and PBMCs separated on lymphoprep (Axis-
Shield) columns for use in ELISpot assay.
In the initial cohort, the onset of CMV infection was diagnosed
by the excretion of CMV DNA in the urine, as the infants were
young enough for serological testing to be confounded by
maternally derived IgG. As maternally derived antibodies would
have been cleared by two years of age, the infection status of
infants that were not known to be positive was assessed by testing
for CMV-specific IgG with an ELICYTOK-G ELISA (Diasorin).
None of the infants showed any CMV-related pathology.
Flow cytometry
All flow cytometry reagents were from Becton Dickinson. The
CD8 population was identified using PerCP-conjugated anti-CD8
antibody. Preliminary experiments demonstrated that it was
possible to identify a pure population of CD3
+CD8
high T-cells
and that T-cells binding tetramers expressed CD8 at the same high
level (unpublished data). Further staining for surface markers was
carried out using APC-conjugated antibodies to CD27, CD45R0,
CD62L and CD38, and FITC-conjugated antibodies to CD28,
CD45RA, CD95 and the class II HLA-D molecules DR, DP and
DQ. Intracellular markers were identified using FITC-conjugated
antibodies to Bcl-2, Ki-67, perforin and granzyme A. Where
possible, cells specific for the immunodominant pp65 protein of
CMV [3] were identified with PE-conjugated B7-TPRVGGGAM
and A2-NLVPMVATV tetramers, synthesised as previously
described [17,18]. Red blood cells were lysed using FACSlyse
solution and lymphocytes were permeabilised using FACSperm II.
Samples were acquired on a four-colour FACSCalibur.
Analysis of flow cytometry data
The flow cytometry analysis of the samples collected during the
first year of follow-up were analysed using the automatic
processing tool that was developed to analyse the first 12 months
of data [15,19]. Cut-offs and subpopulation statistics from the
automatic gating algorithms are written directly to an Access
database (Microsoft), and read directly from the database into
Stata 9 (Statcorp) for analysis.
The 12 and 24 month post-diagnosis timepoints were compared
using a random effects model which allowed for those subjects that
had observations at both timepoints. Where necessary responses
were appropriately transformed to improve the normality and
constant variance regression assumptions. A cross-sectional
analysis was used to compare CMV infected with uninfected
subjects at 24 months. Interactions between tetramer
+ and
tetramer
2 populations and follow-up time were tested and if not
significant at the 5% level, comparisons were based on the main
effects of tetramer and follow-up time.
ELISpot
A kit for the detection of IFNc (Mabtech) was used with
polyvinylidene difluoride-coated microplates (Millipore) in ELISpot
assays. The peptides used were the A2-restricted MLNIPSINV,
NLVPMVATV, VLGPISGHV, YILEETSVM and IAGN-
SAYEYV, the B7-restricted RPHERNGFTV, TPRVTGGGAM
CD8 T-Cells in CMV Infection
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VFPTKDVAL, and the B8-restricted DANDIYRIF [20–26].
A detectable response was defined as a mean treatment spot
count that was more than 10SFU 10
5 cells
21 greater than twice
the mean negative control. These criteria have previously been
found to provide high specificity while allowing reasonable
sensitivity in the detection of peptide-specific responses [15,27].
Responses were measured as specific spot forming units (SFU),
calculated as the difference between the mean treatment spot
count and the mean negative control spot count. Data were
analysed using Stata 9, and MINITAB 14 (MINITAB inc).
Results
Infection with CMV was almost universal by 24 months of
age
Of the infants that had been uninfected at twelve months of age,
17 were identified and tested at 24 months and 12 (70%) were
seropositive. At twelve months of age, 85% of infants were infected
and assuming that the infection rate among the infants that were
followed up was representative of all infants uninfected by twelve
months, the infection rate at 24 months of age had risen to 96%.
Relative sizes of activated and CMV-specific
subpopulations remained constant in the second year
after CMV diagnosis
Cells specific for CMV were identified by tetramer staining, and
the frequencies of tetramer-specific cells were compared between
12 and 24 months post-diagnosis using a random effects model
that allowed for the incorporation of subjects for whom data for
one or other timepoint was missing.
As in the first year after diagnosis, there was considerable
variability in the proportions of CD8 T-cells that responded to a
single tetramer at the end of the second year, with frequencies
ranging from 0.2% to 8.2% of the total CD8 T-cell population.
Nevertheless, the relative sizes of the peptide-specific subpopula-
tions within individuals remained similar to the proportions that
had been maintained throughout the first two years following
diagnosis (data not shown).
Declining activation among CD8 T-cells during the
second year after diagnosis
Markers of activation were identified by flow cytometry and their
frequency was compared among tetramer
+ cells and the overall
Figure 1. Tetramer
+ CD8 T-cells are more activated than the overall CD8 T-cell population, but no more so at 24 than 12 months
post-diagnosis. A histograms of the expression of Ki-67 in the overall CD8 T-cell population and tetramer
+ subpopulation of a representative
sample collected 24 months post-diagnosis, with individual value plots indicating proportions of Ki-67
+. B scatter plots of the expression of CD45R0
and CD45RA in the overall CD8 T-cell population and tetramer
+ subpopulation of a representative sample collected 24 months post-diagnosis, with
individual value plots indicating proportions of CD45R0
+ cells and the CD45 ratio derived from all samples. C scatter plots of the expression of
CD45R0 and HLA-D in the overall CD8 T-cell population and tetramer
+ subpopulation of a representative sample collected 24 months post-diagnosis,
with individual value plots indicating proportions of HLA-D
+ and CD45R0
+HLA-D
+ cells and the CD45 ratio derived from all samples. Significances
indicate differences between both overall and tetramer
+ subpopulations. Grey bars indicate means. Significant differences between tetramer
+ and
overall CD8 T-cell populations are indicated by *p,0.05, **p,0.005 or ***p,0.0005.
doi:10.1371/journal.pone.0002905.g001
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defined by Ki-67 expression [28], was low in both the tetramer
+
subpopulationand the overall CD8T-cell populationand remained
low throughout the second year post-diagnosis (Fig 1A).
Cells stained with CD45RA and CD45R0 were divided into a
CD45RA
bright subpopulation that did not express CD45R0 and a
more activated CD45R0
+ subpopulation that expressed both
isoforms in approximately reciprocal quantities [29,30]. The
CD45R0
+ subpopulation was more common among tetramer
+
cells than among the overall population (p,0.0001) (Fig 1B).
Although the proportion of CD45R0
+ cells had declined
through the first year post-diagnosis, it actually increased slightly
during the second year among both the tetramer
+ cells and the
overall CD8 T-cell population (Fig 1B).
Activation was further explored by costaining to identify
subpopulations that expressed HLA-D, which indicated the
secondary expression of class II HLA on activation [31], or
coexpressed HLA-D and CD45R0. Tetramer
+ CD8 T-cells
tended to have higher proportions of both the HLA-D
+
(p=0.012) and HLA-D
+CD45R0
+ (p=0.001) subpopulations,
providing further evidence that they were more activated than the
CD8 T-cell population as a whole. Proportions of cells both
subpopulations fell during the first year following expression
among both the overall and tetramer
+ CD8 T-cells, but unlike
cells expressing CD45R0, the fall continued during the second
year of infection among both the HLA-D
+ (p=0.021) and HLA-
D
+CD45R0
+ subpopulations (p=0.008) (Fig 1C).
Levels of differentiation remained stable or dropped
during the second year post-diagnosis
Differentiation was evaluated by stratifying CD8 T-cells into
undifferentiated (CD27
+CD28
+), intermediate (CD27
+CD28
2)a n d
fully differentiated (CD27
2CD28
2) subpopulations [30,32–34].
There were consistently more intermediate and fully differentiated
cells among the tetramer
+ subpopulation than among the overall
CD8 T-cell population throughout the second year post-diagnosis
(Fig 2A), as there had been throughout the first year.
During the second year post-diagnosis, there were slight but
significant increases in the proportions of cells falling into both the
undifferentiated (p=0.002) and intermediate (p=0.001) subpop-
ulations among both tetramer
+ cells and the overall CD8 T-cell
population. There was a corresponding decrease in the proportion
of fully differentiated cells among the total CD8 T-cell population
(p=0.018), which was not mirrored by a significant decrease
among tetramer
+ cells (Fig 2A).
As CD8 T-cells differentiate, they express cytotoxic perforin and
granzymes [29,33,35]. Consequently, when the stain for CD28
was replaced with a stain for perforin or granzyme A, most
Figure 2. Tetramer
+ cells are more differentiated than the overall CD8 T-cell population, but there is little change in the relative
proportions of the subpopulations in the second year post-diagnosis. A Scatter plots of the expression of CD27 and CD28 gated on all CD8
T-cells and on tetramer
+ CD8 T-cells, and individual value plots of the percentages of cells that fell into each of the defined subpopulations within the
overall CD8 and tetramer
+ populations. B Scatter plots of the expression of CD27 and perforin gated on all CD8 T-cells and on tetramer
+ CD8 T-cells,
and individual value plots of the percentages of cells that fell into each of the defined subpopulations within the overall CD8 and tetramer
+
populations. C Scatter plots of the expression of CD27 and granzyme A gated on all CD8 T-cells and on tetramer
+ CD8 T-cells, and individual value
plots of the percentages of cells that fell into each of the defined subpopulations within the overall CD8 and tetramer
+ populations. Significant
differences between sample times are indicated where present. Grey bars indicate means. Significant differences between tetramer
+ and overall CD8
T-cell populations are indicated by *p,0.05, **p,0.005 or ***p,0.0005.
doi:10.1371/journal.pone.0002905.g002
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+ cells were among the differentiated subpopulations that
expressed perforin (Fig 2B) and granzyme A (Fig 2C). Similar
trends to those shown by staining of CD28 were evident, although
they were not always significant.
Cells stained for CD62L and CD95 were divided into a
relatively undifferentiated CD62L
+ subpopulation [30,36] that
incorporated cells that expressed various levels of CD95, and a
CD62L
2 subpopulation in which nearly all cells expressed CD95
(Fig 3A). Far more of the tetramer
+ cells than the total CD8 T-cells
had lost expression of CD62L, and the proportions remained
relatively constant throughout the first [15] and second (Fig 3B)
years post-diagnosis.
Expression of Bcl-2 in the second year post-diagnosis also
followed the same trends as it had throughout the first, in that the
vast majority of the tetramer
+ cells fell into the relatively
differentiated Bcl-2
low subpopulation [37] while the overall CD8
T-cell population was more evenly split between the two, and the
relative proportions did not change significantly (Fig 3C, D).
The CD8 T-cells of CMV-infected infants were more
differentiated but no more activated than those of CMV-
uninfected infants
At 12 months of age, the vast majority of the CD8 T-cells of CMV-
uninfected infants had been among the undifferentiated (CD27
+,
CD28
+,C D 6 2 L
+,p e r f o r i n
2,g r a n z y m eA
2) subpopulations while
those of CMV-infected subjects of equivalent age had shown
substantial proportions of differentiated cells. The expression of
markers of activation such as CD45R0, HLA-D and Ki-67 had been
unaffected by CMV status [15]. Very few CMV-uninfected subjects
remained by 24 months of age and the CD8 T-cell phenotype was
only assessed on two, both sampled at 112 weeks of age. While the
low numbers precluded statistical comparisons, the CD8 T-cells of
uninfected infants remained considerably less differentiated than
those of most of their CMV-infected peers.
At least 80% of the CD8 T-cells of the CMV-uninfected infants
fell into the CD27
+CD28
+ subpopulation while the mean for the
CMV-infected infants was 66% (Fig. 4A), and the lower value for
the CD62L
+ subpopulation among CMV-uninfected infants was
84% while the mean for CMV-infected infants was 67% (Fig. 4B).
Differences of smaller magnitude in the expression of markers of
activation were also seen. For instance, the mean size of the
CD45RA
bright subpopulation was 38% among CMV-uninfected
infants and 26% among CMV-infected infants (Fig. 4C) and the
mean sizes of the HLA-D subpopulations were 12% in uninfected
and 19% in infected (Fig. 4D). While the activated subpopulations
were numerically larger in CMV-infected infants in all examples, the
standard deviations among the CMV-infected infants were always
greater than half of the value of the mean so the differences were
considerably less evident than among markers of differentiation.
Little change in IFNc responses between 12 and 24
months post-diagnosis
Cells were stimulated with peptides containing known immuno-
dominant epitopes, matched with the appropriate class I HLA
restriction. The frequency of IFNc-producing cells was quantified
by ELISpot and compared between 12 and 24 months. Infants with
the capacity to respond were identified as those with CD8 T-cells
that had recognised one of the two tetramers incorporating the
Figure 3. A higher proportion of CD8 T-cells were CD62L
+ at 24 months than 12, but distribution between the Bcl-2
low and Bcl-2
high
subpopulations remained constant. A Scatter plots of expression of CD62L and CD95 in the overall T-cell population at 12 and 24 months post-
diagnosis in a representative sample. B Individual value plots of proportions of CD62L
+ cells among tetramer
+ and overall CD8 T-cell populations at
12 and 24 months post-diagnosis. C Histograms of expression of Bcl-2 in the overall T-cell population at 12 and 24 months post-diagnosis in a
representative sample. D Individual value plots of proportions of Bcl2
low cells among tetramer
+ and overall CD8 T-cell populations at 12 and 24
months post-diagnosis. Grey bars indicate means. Significant differences between sample times are indicated where present. ** indicates difference
between tetramer
+ cells and overall population significant at p,0.005.
doi:10.1371/journal.pone.0002905.g003
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infants at 24 months of age. A Scatter plots of expression of CD27 and CD28 in representative samples and relative sizes of the three defined
subpopulations in all infants sampled at 24 months of age. B Scatter plots of expression of CD62L and CD95 in representative samples and relative
sizes of the CD62L
+ subpopulation in all infants sampled at 24 months of age. C Scatter plots of expression of CD45R0 and CD45RA in representative
samples and relative sizes of the CD45RA
brightCD45R0
2 subpopulation in all infants sampled at 24 months of age. D Scatter plots of expression of
CD45R0 and HLA-D in representative samples and relative sizes of the HLA-D
+ subpopulation in all infants sampled at 24 months of age.
Representative scatter plots are selected as those with the lower proportion of cells in the subpopulation of interest, or the CD27
+CD28
+
subpopulation for part A, among CMV-uninfected infants and the median proportion for CMV-infected infants.
doi:10.1371/journal.pone.0002905.g004
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peptide incorporated into the tetramer rose from 16 of 19 (84%) at
12 months post-diagnosis to 11 of 12 (92%) by 24 months.
As there were a number of peptides used in the ELISpot for which
tetramers were not available, potential responders were alsoidentified
as infants with cells that had produced a detectable IFNc response to
a given peptide in at least one sample. As peptide-specific
subpopulations were stable, differences in their detectability were
unlikely to be due to fluctuations in their frequency and were
considered to represent differences in functional capacity. Based on
these criteria, the number of potential responders that actually
re sp o n d e dr o s ef r o m3 0o f6 8( 4 4 % )a t1 2m o n t h st o1 8o f3 6(5 0 % )a t
24 months.
While both approaches showed an increase in the proportion of
peptide-specific cells that actually responded to the peptide,
neither was statistically significant.
Discussion
We assessed the development of the CD8 T-cell population and
its response to CMV after two years of infection, and compared it
to the response after one year. The most obvious trend throughout
the first year had been for the subpopulations of tetramer
+ cells to
show higher levels of differentiation and activation than the overall
CD8 T-cell population [15]. The same large differences remained
at 24 months post-diagnosis, as it was evident that almost all
CMV-specific cells had lost expression of CD27, CD28 and
CD62L and gained expression of CD95, perforin and granzyme
A, indicating that they were mature differentiated cells with the
potential to kill virus infected cells [32,35,38].
The proportion of CMV-specific CD8 T-cells that are highly
differentiated (CD27
2) is much higher than among CD8 T-cells
specific for other viruses such as EBV, HIV and HCV [32]. We
previously found that the high level of differentiation emerges
rapidly after infection, and these data show that it remains for at
least two years after infection.
Differences in markers of activation were less striking, although
the tetramer
+ cells expressed elevated levels of CD45RA and
HLA-D as they had throughout the first year of infection. The one
element of activity that was not upregulated in CMV-specific cells
at either 12 or 24 months was division, as defined by expression of
Ki-67 [28].
The maintenance of the subpopulations specific for tetramers
incorporating the immunodominant pp65 protein indicated no
ablation of CMV-specific cells within the CD8 T-cell population,
and several individuals retained substantial subpopulations that
responded to a single peptide. The long-term maintenance of these
populations is in contrast to the reduction in the pp65-specific
response over time reported in adults following symptomatic CMV
infection [39] or infection during kidney transplant [2]. It is
possible that the different patterns of development may be due to
the Gambians being infected in infancy or simply that the
reduction of the CD8 T-cell response does not occur in
asymptomatically infected healthy individuals. Given the huge
number of potential epitopes expressed by CMV [3], it is likely
that the tetramers were only detecting a small proportion of the
overall CMV-specific T-cells and that a substantial proportion of
all CD8 T-cells were devoted to the response to CMV.
A substantial subpopulation of all CD8 T-cells had assumed a
differentiated, cytotoxic phenotype immediately after diagnosis and
the relative size of the subpopulation remained stable throughout
the first year of infection. Very few changes were evident 24 months
post-diagnosis as there were no changes in the expression of Bcl-2,
CD62L or CD95. There was a slight shift of cells from the fully
differentiated to the undifferentiated and intermediate subpopula-
tions as defined by CD27 and CD28, indicating that differentiation
may not be maintained at the same high levels as in the first year of
infection, although the tendency of CD8 T-cells of chronically
infected adults to retain a large differentiated subpopulation [6,7]
suggests that the populations of the Gambian infants will never
approach their pre-infection levels of differentiation.
At 12 months post-diagnosis, the CD8 T-cell populations of
CMV-uninfected individuals contained very few differentiated cells
[15] and we concluded that CMV drove differentiation in Gambian
children in the same way that has been shown in European adults
[8,40,41]. Unfortunately with the very low numbers of infants that
remained uninfected by 24 months of age, formal statistical analysis
is not justified. Nevertheless, the difference in the mean level of
differentiated cells between infected and uninfected individuals
remained considerable, suggesting that the influence of CMV
infection on driving CD8 T-cell differentiation was as important at
24 months of age as it had been at 12.
In contrast to the stability of the differentiated subpopulation,
the proportion of cells expressing markers of activation such as
CD45R0 and HLA-D fell during the first year post-diagnosis to
similar levels to those of CMV-uninfected infants. During the
second year, the patterns followed by the two markers diverged as
the proportion of HLA-D
+ cells continued to fall while the
proportion of CD45R0
+ cells actually rose slightly. Similar
increases in CD45R0 expression among CD8 T-cells during
childhood were observed in the absence of changes in HLA-D
expression in a Dutch cohort where CMV infection was probably
rare [42], implying that the expression of CD45 isoforms may be
more sensitive to the accumulation of antigen exposure during
childhood than the expression of HLA-D.
Several studies have shown that the CD8 T-cells of children and
infants of equivalent age to those whom we sampled have a weak
IFNc response to viral infections [43–45] including CMV [4],
making it unlikely that the IFNc responses of the infants in the subco-
horthadpeaked.However,theslightincreaseinthesecondyearpost-
diagnosis, which corresponded to the third year of life for the older
children in the sub-cohort, implied that the rate of any increase was
considerably less than had been observed in the first year.
In summary, CMV-specific CD8 T-cells remained more activated
and differentiated than the overall CD8 T-cell population at the end
of the second year of CMV infection. The drop in activation markers
among the total CD8 T-cell population that had been clear during
the first year following infection was less clear in the second as while
the frequency of cells expressing HLA-D continued to drop, the
frequency expressing CD45R0 increased slightly. There was a slight
but non-significant rise in the proportion of CMV-specific CD8 T-
cells that produced IFNc in response to CMV peptides, indicating
that any increase in CD8 T-cell function was considerably less
dramatic than it had been during the first two years of life.
Nevertheless, the large sizes of peptide-specific clones and continued
stability of a large differentiated subpopulation of CD8 T-cells that
w a sa b s e n tf r o mu n i n f e c t e di n f a n t si n d i c a t e dt h a tC M Vc o n t i n u e dt o
be a major determinant of the state of the CD8 T-cell population.
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